Literature DB >> 9784574

Effect of P39 gene deletion in live Brucella vaccine strains on residual virulence and protective activity in mice.

A Tibor1, I Jacques, L Guilloteau, J M Verger, M Grayon, V Wansard, J J Letesson.   

Abstract

The 39-kilodalton protein (P39) has previously been shown to be an immunodominant protein in Brucella infections. P39 gene deletion mutants of vaccine strains Brucella abortus S19 and Brucella melitensis Rev.1 were constructed by gene replacement. This deletion did not significantly modify the residual virulence of both vaccine strains in CD-1 mice. CD-1 mice vaccinated with the parent or mutant strains were protected against a virulent challenge. Mutant vaccine strains devoid of P39 could provide a means for differentiating vaccinated from infected animals.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9784574      PMCID: PMC108700     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  [Transformatinon normalizing the distribution of the number of Brucella organisms in the spleen of rats vaccinated intraperitoneally].

Authors:  N Bosseray; M Plommet
Journal:  J Biol Stand       Date:  1976

2.  [Checking of anti-Brucella vaccines by counting the Brucella in the spleen of intraperitoneally innoculated, vaccinated or unvaccinated, mice].

Authors:  M Plommet; N Bosseray
Journal:  J Biol Stand       Date:  1977

3.  Brucella suis S2, brucella melitensis Rev. 1 and Brucella abortus S19 living vaccines: residual virulence and immunity induced against three Brucella species challenge strains in mice.

Authors:  N Bosseray; M Plommet
Journal:  Vaccine       Date:  1990-10       Impact factor: 3.641

4.  An evaluation of the delayed-type hypersensitivity test for diagnosing brucellosis in individual cattle: a field study.

Authors:  Z Bercovich; E A ter Laak
Journal:  Vet Microbiol       Date:  1990-04       Impact factor: 3.293

5.  Specific bovine brucellosis diagnosis based on in vitro antigen-specific gamma interferon production.

Authors:  V Weynants; J Godfroid; B Limbourg; C Saegerman; J J Letesson
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

6.  Antibody response to the 89-kDa outer membrane protein of Brucella in bovine brucellosis.

Authors:  J N Limet; A Cloeckaert; G Bezard; J Van Broeck; G Dubray
Journal:  J Med Microbiol       Date:  1993-12       Impact factor: 2.472

7.  Theoretical, practical and statistical basis for a general control method of activity for anti-Brucella vaccines.

Authors:  N Bosseray; A M Plommet; M Plommet
Journal:  Dev Biol Stand       Date:  1984

8.  Cattle serologically positive for Brucella abortus have antibodies to B. abortus Cu-Zn superoxide dismutase.

Authors:  L B Tabatabai; S G Hennager
Journal:  Clin Diagn Lab Immunol       Date:  1994-09

9.  Identification of sero-reactive Brucella melitensis cytosoluble proteins which discriminate between antibodies elicited by infection and Rev.1 vaccination in sheep.

Authors:  H S Debbarh; A Cloeckaert; M S Zygmunt; G Dubray
Journal:  Vet Microbiol       Date:  1995-04       Impact factor: 3.293

10.  Cloning and sequence analysis of a newly identified Brucella abortus gene and serological evaluation of the 17-kilodalton antigen that it encodes.

Authors:  F Hemmen; V Weynants; T Scarcez; J J Letesson; E Saman
Journal:  Clin Diagn Lab Immunol       Date:  1995-05
View more
  6 in total

1.  Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kilodalton outer membrane protein of Brucella abortus.

Authors:  R Vemulapalli; S Cravero; C L Calvert; T E Toth; N Sriranganathan; S M Boyle; O L Rossetti; G G Schurig
Journal:  Clin Diagn Lab Immunol       Date:  2000-01

2.  Protection of mice against brucellosis by vaccination with Brucella melitensis WR201(16MDeltapurEK).

Authors:  D L Hoover; R M Crawford; L L Van De Verg; M J Izadjoo; A K Bhattacharjee; C M Paranavitana; R L Warren; M P Nikolich; T L Hadfield
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

3.  Brucella abortus genes identified following constitutive growth and macrophage infection.

Authors:  L Eskra; A Canavessi; M Carey; G Splitter
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

4.  Progress in Brucella vaccine development.

Authors:  Xinghong Yang; Jerod A Skyberg; Ling Cao; Beata Clapp; Theresa Thornburg; David W Pascual
Journal:  Front Biol (Beijing)       Date:  2013-02-01

Review 5.  The Case for Live Attenuated Vaccines against the Neglected Zoonotic Diseases Brucellosis and Bovine Tuberculosis.

Authors:  Aseem Pandey; Ana Cabello; Lavoisier Akoolo; Allison Rice-Ficht; Angela Arenas-Gamboa; David McMurray; Thomas A Ficht; Paul de Figueiredo
Journal:  PLoS Negl Trop Dis       Date:  2016-08-18

6.  Kinetics of Placental Infection by Different Smooth Brucella Strains in Mice.

Authors:  Irati Poveda-Urkixo; Gustavo A Ramírez; María-Jesús Grilló
Journal:  Pathogens       Date:  2022-02-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.